Global Oncolytic Virus Therapy Market Size, Status and Forecast 2023

Report ID: 1234618 | Published Date: Jan 2025 | No. of Page: 109 | Base Year: 2024 | Rating: 4.4 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Oncolytic Virus Therapy Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 HSV-based Oncolytic Viruses
        1.2.3 Adenoviruses-based Oncolytic Viruses
        1.2.4 Vaccinia Virus-based Oncolytic Viruses
        1.2.5 Vesicular Stomatitis Virus-based Oncolytic Viruses
        1.2.6 Newcastle Disease Virus-based Oncolytic Viruses
    1.3 Market by Application
        1.3.1 Global Oncolytic Virus Therapy Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Melanoma
        1.3.3 Prostate Cancer
        1.3.4 Breast Cancer
        1.3.5 Ovarian Cancer
        1.3.6 Others
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Oncolytic Virus Therapy Market Perspective (2016-2027)
    2.2 Oncolytic Virus Therapy Growth Trends by Regions
        2.2.1 Oncolytic Virus Therapy Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Oncolytic Virus Therapy Historic Market Share by Regions (2016-2021)
        2.2.3 Oncolytic Virus Therapy Forecasted Market Size by Regions (2022-2027)
    2.3 Oncolytic Virus Therapy Industry Dynamic
        2.3.1 Oncolytic Virus Therapy Market Trends
        2.3.2 Oncolytic Virus Therapy Market Drivers
        2.3.3 Oncolytic Virus Therapy Market Challenges
        2.3.4 Oncolytic Virus Therapy Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Oncolytic Virus Therapy Players by Revenue
        3.1.1 Global Top Oncolytic Virus Therapy Players by Revenue (2016-2021)
        3.1.2 Global Oncolytic Virus Therapy Revenue Market Share by Players (2016-2021)
    3.2 Global Oncolytic Virus Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Oncolytic Virus Therapy Revenue
    3.4 Global Oncolytic Virus Therapy Market Concentration Ratio
        3.4.1 Global Oncolytic Virus Therapy Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Oncolytic Virus Therapy Revenue in 2020
    3.5 Oncolytic Virus Therapy Key Players Head office and Area Served
    3.6 Key Players Oncolytic Virus Therapy Product Solution and Service
    3.7 Date of Enter into Oncolytic Virus Therapy Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Oncolytic Virus Therapy Breakdown Data by Type
    4.1 Global Oncolytic Virus Therapy Historic Market Size by Type (2016-2021)
    4.2 Global Oncolytic Virus Therapy Forecasted Market Size by Type (2022-2027)

5 Oncolytic Virus Therapy Breakdown Data by Application
    5.1 Global Oncolytic Virus Therapy Historic Market Size by Application (2016-2021)
    5.2 Global Oncolytic Virus Therapy Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Oncolytic Virus Therapy Market Size (2016-2027)
    6.2 North America Oncolytic Virus Therapy Market Size by Type
        6.2.1 North America Oncolytic Virus Therapy Market Size by Type (2016-2021)
        6.2.2 North America Oncolytic Virus Therapy Market Size by Type (2022-2027)
        6.2.3 North America Oncolytic Virus Therapy Market Size by Type (2016-2027)
    6.3 North America Oncolytic Virus Therapy Market Size by Application
        6.3.1 North America Oncolytic Virus Therapy Market Size by Application (2016-2021)
        6.3.2 North America Oncolytic Virus Therapy Market Size by Application (2022-2027)
        6.3.3 North America Oncolytic Virus Therapy Market Size by Application (2016-2027)
    6.4 North America Oncolytic Virus Therapy Market Size by Country
        6.4.1 North America Oncolytic Virus Therapy Market Size by Country (2016-2021)
        6.4.2 North America Oncolytic Virus Therapy Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Oncolytic Virus Therapy Market Size (2016-2027)
    7.2 Europe Oncolytic Virus Therapy Market Size by Type
        7.2.1 Europe Oncolytic Virus Therapy Market Size by Type (2016-2021)
        7.2.2 Europe Oncolytic Virus Therapy Market Size by Type (2022-2027)
        7.2.3 Europe Oncolytic Virus Therapy Market Size by Type (2016-2027)
    7.3 Europe Oncolytic Virus Therapy Market Size by Application
        7.3.1 Europe Oncolytic Virus Therapy Market Size by Application (2016-2021)
        7.3.2 Europe Oncolytic Virus Therapy Market Size by Application (2022-2027)
        7.3.3 Europe Oncolytic Virus Therapy Market Size by Application (2016-2027)
    7.4 Europe Oncolytic Virus Therapy Market Size by Country
        7.4.1 Europe Oncolytic Virus Therapy Market Size by Country (2016-2021)
        7.4.2 Europe Oncolytic Virus Therapy Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Oncolytic Virus Therapy Market Size (2016-2027)
    8.2 Asia-Pacific Oncolytic Virus Therapy Market Size by Type
        8.2.1 Asia-Pacific Oncolytic Virus Therapy Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Oncolytic Virus Therapy Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Oncolytic Virus Therapy Market Size by Type (2016-2027)
    8.3 Asia-Pacific Oncolytic Virus Therapy Market Size by Application
        8.3.1 Asia-Pacific Oncolytic Virus Therapy Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Oncolytic Virus Therapy Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Oncolytic Virus Therapy Market Size by Application (2016-2027)
    8.4 Asia-Pacific Oncolytic Virus Therapy Market Size by Region
        8.4.1 Asia-Pacific Oncolytic Virus Therapy Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Oncolytic Virus Therapy Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Oncolytic Virus Therapy Market Size (2016-2027)
    9.2 Latin America Oncolytic Virus Therapy Market Size by Type
        9.2.1 Latin America Oncolytic Virus Therapy Market Size by Type (2016-2021)
        9.2.2 Latin America Oncolytic Virus Therapy Market Size by Type (2022-2027)
        9.2.3 Latin America Oncolytic Virus Therapy Market Size by Type (2016-2027)
    9.3 Latin America Oncolytic Virus Therapy Market Size by Application
        9.3.1 Latin America Oncolytic Virus Therapy Market Size by Application (2016-2021)
        9.3.2 Latin America Oncolytic Virus Therapy Market Size by Application (2022-2027)
        9.3.3 Latin America Oncolytic Virus Therapy Market Size by Application (2016-2027)
    9.4 Latin America Oncolytic Virus Therapy Market Size by Country
        9.4.1 Latin America Oncolytic Virus Therapy Market Size by Country (2016-2021)
        9.4.2 Latin America Oncolytic Virus Therapy Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Oncolytic Virus Therapy Market Size (2016-2027)
    10.2 Middle East & Africa Oncolytic Virus Therapy Market Size by Type
        10.2.1 Middle East & Africa Oncolytic Virus Therapy Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Oncolytic Virus Therapy Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Oncolytic Virus Therapy Market Size by Type (2016-2027)
    10.3 Middle East & Africa Oncolytic Virus Therapy Market Size by Application
        10.3.1 Middle East & Africa Oncolytic Virus Therapy Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Oncolytic Virus Therapy Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Oncolytic Virus Therapy Market Size by Application (2016-2027)
    10.4 Middle East & Africa Oncolytic Virus Therapy Market Size by Country
        10.4.1 Middle East & Africa Oncolytic Virus Therapy Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Oncolytic Virus Therapy Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Amgen
        11.1.1 Amgen Company Details
        11.1.2 Amgen Business Overview
        11.1.3 Amgen Oncolytic Virus Therapy Introduction
        11.1.4 Amgen Revenue in Oncolytic Virus Therapy Business (2016-2021)
        11.1.5 Amgen Recent Development
    11.2 Oncolytics Biotech
        11.2.1 Oncolytics Biotech Company Details
        11.2.2 Oncolytics Biotech Business Overview
        11.2.3 Oncolytics Biotech Oncolytic Virus Therapy Introduction
        11.2.4 Oncolytics Biotech Revenue in Oncolytic Virus Therapy Business (2016-2021)
        11.2.5 Oncolytics Biotech Recent Development
    11.3 Viralytics
        11.3.1 Viralytics Company Details
        11.3.2 Viralytics Business Overview
        11.3.3 Viralytics Oncolytic Virus Therapy Introduction
        11.3.4 Viralytics Revenue in Oncolytic Virus Therapy Business (2016-2021)
        11.3.5 Viralytics Recent Development
    11.4 Transgene SA
        11.4.1 Transgene SA Company Details
        11.4.2 Transgene SA Business Overview
        11.4.3 Transgene SA Oncolytic Virus Therapy Introduction
        11.4.4 Transgene SA Revenue in Oncolytic Virus Therapy Business (2016-2021)
        11.4.5 Transgene SA Recent Development
    11.5 Oncolys BioPharma
        11.5.1 Oncolys BioPharma Company Details
        11.5.2 Oncolys BioPharma Business Overview
        11.5.3 Oncolys BioPharma Oncolytic Virus Therapy Introduction
        11.5.4 Oncolys BioPharma Revenue in Oncolytic Virus Therapy Business (2016-2021)
        11.5.5 Oncolys BioPharma Recent Development
    11.6 Targovax
        11.6.1 Targovax Company Details
        11.6.2 Targovax Business Overview
        11.6.3 Targovax Oncolytic Virus Therapy Introduction
        11.6.4 Targovax Revenue in Oncolytic Virus Therapy Business (2016-2021)
        11.6.5 Targovax Recent Development
    11.7 PsiOxus Therapeutics
        11.7.1 PsiOxus Therapeutics Company Details
        11.7.2 PsiOxus Therapeutics Business Overview
        11.7.3 PsiOxus Therapeutics Oncolytic Virus Therapy Introduction
        11.7.4 PsiOxus Therapeutics Revenue in Oncolytic Virus Therapy Business (2016-2021)
        11.7.5 PsiOxus Therapeutics Recent Development
    11.8 SillaJen Biotherapeutics
        11.8.1 SillaJen Biotherapeutics Company Details
        11.8.2 SillaJen Biotherapeutics Business Overview
        11.8.3 SillaJen Biotherapeutics Oncolytic Virus Therapy Introduction
        11.8.4 SillaJen Biotherapeutics Revenue in Oncolytic Virus Therapy Business (2016-2021)
        11.8.5 SillaJen Biotherapeutics Recent Development
    11.9 Sorrento Therapeutics
        11.9.1 Sorrento Therapeutics Company Details
        11.9.2 Sorrento Therapeutics Business Overview
        11.9.3 Sorrento Therapeutics Oncolytic Virus Therapy Introduction
        11.9.4 Sorrento Therapeutics Revenue in Oncolytic Virus Therapy Business (2016-2021)
        11.9.5 Sorrento Therapeutics Recent Development
    11.10 Lokon Pharma
        11.10.1 Lokon Pharma Company Details
        11.10.2 Lokon Pharma Business Overview
        11.10.3 Lokon Pharma Oncolytic Virus Therapy Introduction
        11.10.4 Lokon Pharma Revenue in Oncolytic Virus Therapy Business (2016-2021)
        11.10.5 Lokon Pharma Recent Development
    11.11 Genelux Corporation
        11.11.1 Genelux Corporation Company Details
        11.11.2 Genelux Corporation Business Overview
        11.11.3 Genelux Corporation Oncolytic Virus Therapy Introduction
        11.11.4 Genelux Corporation Revenue in Oncolytic Virus Therapy Business (2016-2021)
        11.11.5 Genelux Corporation Recent Development
    11.12 Vyriad
        11.12.1 Vyriad Company Details
        11.12.2 Vyriad Business Overview
        11.12.3 Vyriad Oncolytic Virus Therapy Introduction
        11.12.4 Vyriad Revenue in Oncolytic Virus Therapy Business (2016-2021)
        11.12.5 Vyriad Recent Development
    11.13 TILT Biotherapeutics
        11.13.1 TILT Biotherapeutics Company Details
        11.13.2 TILT Biotherapeutics Business Overview
        11.13.3 TILT Biotherapeutics Oncolytic Virus Therapy Introduction
        11.13.4 TILT Biotherapeutics Revenue in Oncolytic Virus Therapy Business (2016-2021)
        11.13.5 TILT Biotherapeutics Recent Development
    11.14 Cold Genesys
        11.14.1 Cold Genesys Company Details
        11.14.2 Cold Genesys Business Overview
        11.14.3 Cold Genesys Oncolytic Virus Therapy Introduction
        11.14.4 Cold Genesys Revenue in Oncolytic Virus Therapy Business (2016-2021)
        11.14.5 Cold Genesys Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Oncolytic Virus Therapy Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of HSV-based Oncolytic Viruses
    Table 3. Key Players of Adenoviruses-based Oncolytic Viruses
    Table 4. Key Players of Vaccinia Virus-based Oncolytic Viruses
    Table 5. Key Players of Vesicular Stomatitis Virus-based Oncolytic Viruses
    Table 6. Key Players of Newcastle Disease Virus-based Oncolytic Viruses
    Table 7. Global Oncolytic Virus Therapy Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 8. Global Oncolytic Virus Therapy Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 9. Global Oncolytic Virus Therapy Market Size by Regions (2016-2021) & (US$ Million)
    Table 10. Global Oncolytic Virus Therapy Market Share by Regions (2016-2021)
    Table 11. Global Oncolytic Virus Therapy Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 12. Global Oncolytic Virus Therapy Market Share by Regions (2022-2027)
    Table 13. Oncolytic Virus Therapy Market Trends
    Table 14. Oncolytic Virus Therapy Market Drivers
    Table 15. Oncolytic Virus Therapy Market Challenges
    Table 16. Oncolytic Virus Therapy Market Restraints
    Table 17. Global Oncolytic Virus Therapy Revenue by Players (2016-2021) & (US$ Million)
    Table 18. Global Oncolytic Virus Therapy Market Share by Players (2016-2021)
    Table 19. Global Top Oncolytic Virus Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oncolytic Virus Therapy as of 2020)
    Table 20. Ranking of Global Top Oncolytic Virus Therapy Companies by Revenue (US$ Million) in 2020
    Table 21. Global 5 Largest Players Market Share by Oncolytic Virus Therapy Revenue (CR5 and HHI) & (2016-2021)
    Table 22. Key Players Headquarters and Area Served
    Table 23. Key Players Oncolytic Virus Therapy Product Solution and Service
    Table 24. Date of Enter into Oncolytic Virus Therapy Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Oncolytic Virus Therapy Market Size by Type (2016-2021) (US$ Million)
    Table 27. Global Oncolytic Virus Therapy Revenue Market Share by Type (2016-2021)
    Table 28. Global Oncolytic Virus Therapy Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 29. Global Oncolytic Virus Therapy Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 30. Global Oncolytic Virus Therapy Market Size Share by Application (2016-2021) & (US$ Million)
    Table 31. Global Oncolytic Virus Therapy Revenue Market Share by Application (2016-2021)
    Table 32. Global Oncolytic Virus Therapy Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 33. Global Oncolytic Virus Therapy Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 34. North America Oncolytic Virus Therapy Market Size by Type (2016-2021) (US$ Million)
    Table 35. North America Oncolytic Virus Therapy Market Size by Type (2022-2027) & (US$ Million)
    Table 36. North America Oncolytic Virus Therapy Market Size by Application (2016-2021) (US$ Million)
    Table 37. North America Oncolytic Virus Therapy Market Size by Application (2022-2027) & (US$ Million)
    Table 38. North America Oncolytic Virus Therapy Market Size by Country (2016-2021) & (US$ Million) 
    Table 39. North America Oncolytic Virus Therapy Market Size by Country (2022-2027) & (US$ Million) 
    Table 40. Europe Oncolytic Virus Therapy Market Size by Type (2016-2021) (US$ Million)
    Table 41. Europe Oncolytic Virus Therapy Market Size by Type (2022-2027) & (US$ Million)
    Table 42. Europe Oncolytic Virus Therapy Market Size by Application (2016-2021) (US$ Million)
    Table 43. Europe Oncolytic Virus Therapy Market Size by Application (2022-2027) & (US$ Million)
    Table 44. Europe Oncolytic Virus Therapy Market Size by Country (2016-2021) & (US$ Million) 
    Table 45. Europe Oncolytic Virus Therapy Market Size by Country (2022-2027) & (US$ Million) 
    Table 46. Asia-Pacific Oncolytic Virus Therapy Market Size by Type (2016-2021) (US$ Million)
    Table 47. Asia-Pacific Oncolytic Virus Therapy Market Size by Type (2022-2027) & (US$ Million)
    Table 48. Asia-Pacific Oncolytic Virus Therapy Market Size by Application (2016-2021) (US$ Million)
    Table 49. Asia-Pacific Oncolytic Virus Therapy Market Size by Application (2022-2027) & (US$ Million)
    Table 50. Asia-Pacific Oncolytic Virus Therapy Market Size by Region (2016-2021) & (US$ Million) 
    Table 51. Asia-Pacific Oncolytic Virus Therapy Market Size by Region (2022-2027) & (US$ Million) 
    Table 52. Latin America Oncolytic Virus Therapy Market Size by Type (2016-2021) (US$ Million)
    Table 53. Latin America Oncolytic Virus Therapy Market Size by Type (2022-2027) & (US$ Million)
    Table 54. Latin America Oncolytic Virus Therapy Market Size by Application (2016-2021) (US$ Million)
    Table 55. Latin America Oncolytic Virus Therapy Market Size by Application (2022-2027) & (US$ Million)
    Table 56. Latin America Oncolytic Virus Therapy Market Size by Country (2016-2021) & (US$ Million) 
    Table 57. Latin America Oncolytic Virus Therapy Market Size by Country (2022-2027) & (US$ Million) 
    Table 58. Middle East & Africa Oncolytic Virus Therapy Market Size by Type (2016-2021) (US$ Million)
    Table 59. Middle East & Africa Oncolytic Virus Therapy Market Size by Type (2022-2027) & (US$ Million)
    Table 60. Middle East & Africa Oncolytic Virus Therapy Market Size by Application (2016-2021) (US$ Million)
    Table 61. Middle East & Africa Oncolytic Virus Therapy Market Size by Application (2022-2027) & (US$ Million)
    Table 62. Middle East & Africa Oncolytic Virus Therapy Market Size by Country (2016-2021) & (US$ Million) 
    Table 63. Middle East & Africa Oncolytic Virus Therapy Market Size by Country (2022-2027) & (US$ Million) 
    Table 64. Amgen Company Details
    Table 65. Amgen Business Overview
    Table 66. Amgen Oncolytic Virus Therapy Product
    Table 67. Amgen Revenue in Oncolytic Virus Therapy Business (2016-2021) & (US$ Million)
    Table 68. Amgen Recent Development
    Table 69. Oncolytics Biotech Company Details
    Table 70. Oncolytics Biotech Business Overview
    Table 71. Oncolytics Biotech Oncolytic Virus Therapy Product
    Table 72. Oncolytics Biotech Revenue in Oncolytic Virus Therapy Business (2016-2021) & (US$ Million)
    Table 73. Oncolytics Biotech Recent Development
    Table 74. Viralytics Company Details
    Table 75. Viralytics Business Overview
    Table 76. Viralytics Oncolytic Virus Therapy Product
    Table 77. Viralytics Revenue in Oncolytic Virus Therapy Business (2016-2021) & (US$ Million)
    Table 78. Viralytics Recent Development
    Table 79. Transgene SA Company Details
    Table 80. Transgene SA Business Overview
    Table 81. Transgene SA Oncolytic Virus Therapy Product
    Table 82. Transgene SA Revenue in Oncolytic Virus Therapy Business (2016-2021) & (US$ Million)
    Table 83. Transgene SA Recent Development
    Table 84. Oncolys BioPharma Company Details
    Table 85. Oncolys BioPharma Business Overview
    Table 86. Oncolys BioPharma Oncolytic Virus Therapy Product
    Table 87. Oncolys BioPharma Revenue in Oncolytic Virus Therapy Business (2016-2021) & (US$ Million)
    Table 88. Oncolys BioPharma Recent Development
    Table 89. Targovax Company Details
    Table 90. Targovax Business Overview
    Table 91. Targovax Oncolytic Virus Therapy Product
    Table 92. Targovax Revenue in Oncolytic Virus Therapy Business (2016-2021) & (US$ Million)
    Table 93. Targovax Recent Development
    Table 94. PsiOxus Therapeutics Company Details
    Table 95. PsiOxus Therapeutics Business Overview
    Table 96. PsiOxus Therapeutics Oncolytic Virus Therapy Product
    Table 97. PsiOxus Therapeutics Revenue in Oncolytic Virus Therapy Business (2016-2021) & (US$ Million)
    Table 98. PsiOxus Therapeutics Recent Development
    Table 99. SillaJen Biotherapeutics Company Details
    Table 100. SillaJen Biotherapeutics Business Overview
    Table 101. SillaJen Biotherapeutics Revenue in Oncolytic Virus Therapy Business (2016-2021) & (US$ Million)
    Table 102. SillaJen Biotherapeutics Recent Development
    Table 103. Sorrento Therapeutics Company Details
    Table 104. Sorrento Therapeutics Business Overview
    Table 105. Sorrento Therapeutics Oncolytic Virus Therapy Product
    Table 106. Sorrento Therapeutics Revenue in Oncolytic Virus Therapy Business (2016-2021) & (US$ Million)
    Table 107. Sorrento Therapeutics Recent Development
    Table 108. Lokon Pharma Company Details
    Table 109. Lokon Pharma Business Overview
    Table 110. Lokon Pharma Oncolytic Virus Therapy Product
    Table 111. Lokon Pharma Revenue in Oncolytic Virus Therapy Business (2016-2021) & (US$ Million)
    Table 112. Lokon Pharma Recent Development
    Table 113. Genelux Corporation Company Details
    Table 114. Genelux Corporation Business Overview
    Table 115. Genelux Corporation Oncolytic Virus Therapy Product
    Table 116. Genelux Corporation Revenue in Oncolytic Virus Therapy Business (2016-2021) & (US$ Million)
    Table 117. Genelux Corporation Recent Development
    Table 118. Vyriad Company Details
    Table 119. Vyriad Business Overview
    Table 120. Vyriad Oncolytic Virus Therapy Product
    Table 121. Vyriad Revenue in Oncolytic Virus Therapy Business (2016-2021) & (US$ Million)
    Table 122. Vyriad Recent Development
    Table 123. TILT Biotherapeutics Company Details
    Table 124. TILT Biotherapeutics Business Overview
    Table 125. TILT Biotherapeutics Oncolytic Virus Therapy Product
    Table 126. TILT Biotherapeutics Revenue in Oncolytic Virus Therapy Business (2016-2021) & (US$ Million)
    Table 127. TILT Biotherapeutics Recent Development
    Table 128. Cold Genesys Company Details
    Table 129. Cold Genesys Business Overview
    Table 130. Cold Genesys Oncolytic Virus Therapy Product
    Table 131. Cold Genesys Revenue in Oncolytic Virus Therapy Business (2016-2021) & (US$ Million)
    Table 132. Cold Genesys Recent Development
    Table 133. Research Programs/Design for This Report
    Table 134. Key Data Information from Secondary Sources
    Table 135. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Oncolytic Virus Therapy Market Share by Type: 2020 VS 2027
    Figure 2. HSV-based Oncolytic Viruses Features
    Figure 3. Adenoviruses-based Oncolytic Viruses Features
    Figure 4. Vaccinia Virus-based Oncolytic Viruses Features
    Figure 5. Vesicular Stomatitis Virus-based Oncolytic Viruses Features
    Figure 6. Newcastle Disease Virus-based Oncolytic Viruses Features
    Figure 7. Global Oncolytic Virus Therapy Market Share by Application: 2020 VS 2027
    Figure 8. Melanoma Case Studies
    Figure 9. Prostate Cancer Case Studies
    Figure 10. Breast Cancer Case Studies
    Figure 11. Ovarian Cancer Case Studies
    Figure 12. Others Case Studies
    Figure 13. Oncolytic Virus Therapy Report Years Considered
    Figure 14. Global Oncolytic Virus Therapy Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 15. Global Oncolytic Virus Therapy Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 16. Global Oncolytic Virus Therapy Market Share by Regions: 2020 VS 2027
    Figure 17. Global Oncolytic Virus Therapy Market Share by Regions (2022-2027)
    Figure 18. Global Oncolytic Virus Therapy Market Share by Players in 2020
    Figure 19. Global Top Oncolytic Virus Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oncolytic Virus Therapy as of 2020
    Figure 20. The Top 10 and 5 Players Market Share by Oncolytic Virus Therapy Revenue in 2020
    Figure 21. Global Oncolytic Virus Therapy Revenue Market Share by Type (2016-2021)
    Figure 22. Global Oncolytic Virus Therapy Revenue Market Share by Type (2022-2027)
    Figure 23. North America Oncolytic Virus Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 24. North America Oncolytic Virus Therapy Market Share by Type (2016-2027)
    Figure 25. North America Oncolytic Virus Therapy Market Share by Application (2016-2027)
    Figure 26. North America Oncolytic Virus Therapy Market Share by Country (2016-2027)
    Figure 27. United States Oncolytic Virus Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 28. Canada Oncolytic Virus Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 29. Europe Oncolytic Virus Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 30. Europe Oncolytic Virus Therapy Market Share by Type (2016-2027)
    Figure 31. Europe Oncolytic Virus Therapy Market Share by Application (2016-2027)
    Figure 32. Europe Oncolytic Virus Therapy Market Share by Country (2016-2027)
    Figure 33. Germany Oncolytic Virus Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. France Oncolytic Virus Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. U.K. Oncolytic Virus Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. Italy Oncolytic Virus Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 37. Russia Oncolytic Virus Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 38. Nordic Oncolytic Virus Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 39. Asia-Pacific Oncolytic Virus Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 40. Asia-Pacific Oncolytic Virus Therapy Market Share by Type (2016-2027)
    Figure 41. Asia-Pacific Oncolytic Virus Therapy Market Share by Application (2016-2027)
    Figure 42. Asia-Pacific Oncolytic Virus Therapy Market Share by Region (2016-2027)
    Figure 43. China Oncolytic Virus Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. Japan Oncolytic Virus Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. South Korea Oncolytic Virus Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. Southeast Asia Oncolytic Virus Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 47. India Oncolytic Virus Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 48. Australia Oncolytic Virus Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 49. Latin America Oncolytic Virus Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 50. Latin America Oncolytic Virus Therapy Market Share by Type (2016-2027)
    Figure 51. Latin America Oncolytic Virus Therapy Market Share by Application (2016-2027)
    Figure 52. Latin America Oncolytic Virus Therapy Market Share by Country (2016-2027)
    Figure 53. Mexico Oncolytic Virus Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 54. Brazil Oncolytic Virus Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 55. Middle East & Africa Oncolytic Virus Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 56. Middle East & Africa Oncolytic Virus Therapy Market Share by Type (2016-2027)
    Figure 57. Middle East & Africa Oncolytic Virus Therapy Market Share by Application (2016-2027)
    Figure 58. Middle East & Africa Oncolytic Virus Therapy Market Share by Country (2016-2027)
    Figure 59. Turkey Oncolytic Virus Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 60. Saudi Arabia Oncolytic Virus Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 61. UAE Oncolytic Virus Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 62. Amgen Revenue Growth Rate in Oncolytic Virus Therapy Business (2016-2021)
    Figure 63. Oncolytics Biotech Revenue Growth Rate in Oncolytic Virus Therapy Business (2016-2021)
    Figure 64. Viralytics Revenue Growth Rate in Oncolytic Virus Therapy Business (2016-2021)
    Figure 65. Transgene SA Revenue Growth Rate in Oncolytic Virus Therapy Business (2016-2021)
    Figure 66. Oncolys BioPharma Revenue Growth Rate in Oncolytic Virus Therapy Business (2016-2021)
    Figure 67. Targovax Revenue Growth Rate in Oncolytic Virus Therapy Business (2016-2021)
    Figure 68. PsiOxus Therapeutics Revenue Growth Rate in Oncolytic Virus Therapy Business (2016-2021)
    Figure 69. SillaJen Biotherapeutics Revenue Growth Rate in Oncolytic Virus Therapy Business (2016-2021)
    Figure 70. Sorrento Therapeutics Revenue Growth Rate in Oncolytic Virus Therapy Business (2016-2021)
    Figure 71. Lokon Pharma Revenue Growth Rate in Oncolytic Virus Therapy Business (2016-2021)
    Figure 72. Genelux Corporation Revenue Growth Rate in Oncolytic Virus Therapy Business (2016-2021)
    Figure 73. Vyriad Revenue Growth Rate in Oncolytic Virus Therapy Business (2016-2021)
    Figure 74. TILT Biotherapeutics Revenue Growth Rate in Oncolytic Virus Therapy Business (2016-2021)
    Figure 75. Cold Genesys Revenue Growth Rate in Oncolytic Virus Therapy Business (2016-2021)
    Figure 76. Bottom-up and Top-down Approaches for This Report
    Figure 77. Data Triangulation
    Figure 78. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Amgen
Oncolytics Biotech
Viralytics
Transgene SA
Oncolys BioPharma
Targovax
PsiOxus Therapeutics
SillaJen Biotherapeutics
Sorrento Therapeutics
Lokon Pharma
Genelux Corporation
Vyriad
TILT Biotherapeutics
Cold Genesys
Frequently Asked Questions
Oncolytic Virus Therapy report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Oncolytic Virus Therapy report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Oncolytic Virus Therapy report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports